MedAlliance, SELUTION

MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval

11.01.2023 - 10:02:51

MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval. MedAlliance United Kingdom United States of America France Germany Spain Saudi Arabia Qatar Nigeria Morocco Ghana Ethiopia Egypt Malaysia South Africa Zimbabwe

@ prnewswire.co.uk